Literature DB >> 12739310

COPD in VA hospitals.

Jesse Roman1, Rafael L Perez.   

Abstract

The Department of Veterans Affairs (VA) Health Care System is the largest integrated single-payer system in the United States. Its primary mission is to provide primary care, specialized care, and related medical and social support services to veterans. Much time and resources are expended on chronic obstructive pulmonary disease, known as COPD, at VA hospitals and clinics, thereby justifying the development of multifaceted strategies to address this problem. This article discusses the special problems of COPD in veterans who use VA facilities. The article also highlights the contributions of the VA to the research, training, and development of clinical practice guidelines for the management of this pervasive disease and presents the challenges that threaten its role in this area.

Entities:  

Mesh:

Year:  2003        PMID: 12739310     DOI: 10.1016/s1098-3597(03)90007-x

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  4 in total

1.  Insomnia in patients with COPD.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Pooja Budhiraja; Michael P Habib; Christopher Wendel; Stuart F Quan
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

2.  Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years.

Authors:  Christie M Bartels; Carolyn L Bell; Kazuhiko Shinki; Ann Rosenthal; Alan J Bridges
Journal:  Rheumatology (Oxford)       Date:  2010-05-12       Impact factor: 7.580

3.  Adequate initial antidepressant treatment among patients with chronic obstructive pulmonary disease in a cohort of depressed veterans.

Authors:  Paul A Pirraglia; Andrea Charbonneau; Boris Kader; Dan R Berlowitz
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

4.  Canadian Veteran chronic disease prevalence and health services use in the five years following release: a matched retrospective cohort study using routinely collected data.

Authors:  Alyson L Mahar; Kate St Cyr; Jennifer E Enns; Alice B Aiken; Marlo Whitehead; Heidi Cramm; Paul Kurdyak
Journal:  BMC Public Health       Date:  2022-09-05       Impact factor: 4.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.